Humoral immune responses of cancer patients against "cancer-testis" antigen NY-ESO-1: Correlation with clinical events

International Journal of Cancer

Volumn 84, Issue 5, 1999, Pages 506-510

  Jäger, Elke ^a   Srockert, Elisabeth ^a   Zidianakis, Zacharias ^a   Cnen, Yao Tseng ^a   Karbach, Julia ^a   Jäger, Dirk ^a   Arand, Michael ^a   Ritter, Gerd ^a   Old, Lloyd J ^a   Knuth, Alexander ^a  

^a KRANKENHAUS NORDWEST   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; CTAG1B PROTEIN, HUMAN; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; PROTEIN; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER TUMOR; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; MALE; MELANOMA; MIDDLE AGED; NEOPLASM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTIS;

ADULT; AGED; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MELANOMA; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASMS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TESTIS; URINARY BLADDER NEOPLASMS;

EID: 0033595632     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6     Document Type: Article

References (31)

1. ANGELOPOULOU, K., DIAMANDIS, E.P., SUTHERLAND, D.J., KELLEN, J.A. and BUNTING, P.S., Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers. Int. J. Cancer, 58, 480-487 (1994).
2. ANGELOPOULOU, K., STRATIS, M. and DIAMANDIS, E.P., Humoral immune response against p53 protein in patients with colorectal carcinoma. Int. J. Cancer, 70, 46-51(1997).
3. BOON, T. and VAN DER BRUGGEN, P., Human tumor antigens recognized by T lymphocytes. J. Exp. Med., 183, 725-729 (1996).
4. BRASS, N., ECKEL, D., SAHIN, U., PFREUNDSCIIUH, M., SYBRECHT, G.W. and MEESE, E., Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung cancer cells. Hum. Mol. Gen., 6, 33-39 (1997).
5. BRICHARD, V., VAN PEL, A., WÖLFEL, T., WÖLFEL, C., DEPLAEN, E., LETHE, B., COULIE, P. and BOON, T., The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 178, 489-195 (1993).
6. CHEN, Y.-T, CURE, A.O., TSANG, S., STOCKERT, E., JÄGER, E., KNUTH, A. and OLD, L.J., Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc. nail. Acad. Sei. (Wash.). 95, 6919-6923 (1998).
7. CHEN, Y.-T., SCANLAN, M J., SAHIN, U., TÜRECI, O., CURE, A.O., TSANG, S., WILLIAMSON, B., STOCKERT, E., PFREUNDSCHUH, M. and OLD, L.J., A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. natl. Acacl. Sei. (Wash.), 94, 1914-1918(1997).
8. COULIE, P.G., LEIIMANN, E, LETHE, B., HERMAN, J., LURQUIN, C., ANDRAWISS, M. and BOON, T., A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. natl. Acad. Sei. (Wash.), 92, 7976-7980 (1995).
9. FISK, B., BLEVINS, T.L., WIIARTON, J.T. and IONNIDES, C.G., Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines. J. cxp. Med., 181, 2109-2117(1995).
10. GEERING, G., OLD, L.J. and BOYSE, E.A., Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation of the antigens of gross virus and other murine leukemia viruses. J. exp. Med., 124, 753-772 (1966).
11. CURE, A.O., TÜRECI, Ö., SAHIN, U., TSANG, S., SCANLAN, M.J., JÄGER, E., KNUTH, A., PFREUNDSCHUH, M., OLD, L.J. and CHEN, Y.-T., SSX: a multigene family with several members transcribed in normal testis and human cancer. Int. J. Cancer, 72, 965-971 (1997).
12. HUEBNER, R.J., ROWE, W.P., TURNER, H.C. and LANE, W.T., Specific adenovirus complement-fixing antigens in virus-free hamster and rat tumors. Pathology, 50, 379-389 (1963).
13. JÄGER, E., ARAND, M., RINGHOFFER, M., KARBACH, J., JÄGER, D., ILSEMANN, C., HAGEDORN, M., OESCH, F. and KNUTH, A., Cytolytic T cell reactivity against melanoma associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals. Melanoma Res., 6, 419-425 (1996).
14. JÄGER, E., CHEIN, Y.-T., DRIJFHOUT, J.W., KARBACH, J., RINGHOFFER, M., JÄGER, D., ARAND, M., WADA, H., NOGUCHI, Y., STOCKERT, E., OLD, L.J. and KNUTH, A., Simultaneous humoral and cellular immune response against Cancer-Testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J. exp. Med., 187, 265-270(1998).
15. JÄGER, E., RINGHOFFER, M., ALTMANNSBERGER, M., ARAND, M., KARBACH,
16. J., JÄGER, D., OESCH, F. and KSUTH, A., Immunoseleclion in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. Int. J. Cancer, 71, 142-147 (1997).
17. KAWAKAMI, Y., ELIYAHU, S., DELGADO, C.H., ROBBINS, P.P., RIVOLTINI, L., TOPALIAN, S.L., MIKI, T. and ROSENBERG, S.A., Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sei., 91, 3525-3519 (1994).
18. KNUTH, A., DANOWSKI, B., OETTOEN, H.F. and OLD, L.J., T-cell-mediated cytotoxicity aaainst autologous malignant melanoma: analysis with interleukin-2-dependent T-cell cultures. Proc. Natl. Acad. Sei., 81, 3511-3515 (1984).
19. LENNETTE, E.T., WINBERG, G., YADAV, M., ENBLAD, G. and KLEIN, G., Antibodies to LMP2A/2B in EBV-carrying malignancies. Ear. J. Cancer, 31, 18751878(1995).
20. LUBIN, R., SciiLicimioLZ, B., TEILLAUD, J.L., GARAY, E., BUSSEL, A., WILD, C. and Soussi, T., p53 antibodies in patients with various types of cancer: assay, identification and characterization. Clin. Cancer Res., 1, 1463-1469 (1995).
21. MARCHAND, M., WEYMANTS, P., RANKIN, E., ARIENTI, F., BELLI, F., PARMIANI, G., CASCINELLI, N., BOURLOND, A., VANWJICK, R., HUMBLET, Y., CANON, J.-L., LAURENT, C., NAEYAERT, J.-M., PLAGNE, R., DERAEMAEKER, R., KNUTH, A., JÄGER, E., BRASSEUR, F., HERMAN, J., COULIE, P.G. and BOON, T., Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer, 63, 883-885 (1995).
22. OLD, L.J., Cancer immunology: The search for specificity. G.H.A. Clowes Memorial Lecture. Cancer Res., 41, 361-375 (1981).
23. OLD, L.J. and CIIEN, Y.-T, New paths in human cancer serology. J. exp. Med., 187, 1163-1167(1998).
24. SAHIN, U., TÜRECI, Ö., SCIIMITT, H., COCHLOVIUS, B., JOHANNES, T., SCHMITS, R., STENNER, F., Luo, G., SCHOBERT, I. and PFREUNDSCHUH, M., Human neoplasms elicit multiple specific immune responses in the autologous host: Proc. nail. Acad Sei. (Wash.), 92, 11810-11813 (1995).
25. SCANLAN, M., CIIEN, Y.-T., WILLIAMSON, B., CURE, A., STOCKERT, E., GORDON, J., TÜRECI, O., SAHIN, U., PFREUNDSCHUH, M. and OLD, L.J., Characterization of human colon cancer antigens recognized by autologous antibodies. Int. J. Cancer, 76, 652-658 (1998).
26. STOCKERT, E., JÄGER, E., CIIEN, Y.-T., SCANLAN, M.J., GOUT, I., KARBACH, J., ARAND, M., KNUTH, A. and OLD, L.J., A survey of the humoral response of cancer patients to a panel of human tumor antigens. J. exp. Med., 187, 1349-1354(1998).
27. TINDLE, R.W., Human papillomavirus vaccines for cervical cancer. Curr. Opin. Imimmol, 8, 643-650 (1996).
28. TOWBIN, H., STAEHELIN, T. and GORDON, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. nail. Acad. Sei. (Wash.). 76, 4350-4354 (1979).
29. TÜRECI, Ö., SAHIN, U. and PFREUNDSCHUH, M., Serological analysis of human tumor antigens: molecular definition and implications. Mol. Med. 70(%,3, 342-349 (1997).
30. VAN DER BRUGGEN, P., TRAVERSARI, C., CHOMEZ, P., LURQUIN, C., DE PLAEN, E., VAN DEN EYNDE, B., KNUTH, A. and BOON, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643-1647 (1991).
31. WÖLFEL, T., HAUER, M., SCHNEIDER, J., SERRANO, M., WÖLFEL, C., KLEHMANN-HIEB, E., DE PLAEN, E., HANKELN, T, MEYER ZUM BÜSCHENFELDE, K.-H. and BEACH, D., A p!6INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science, 269, 1281-1284(1995).